A Study of Golimumab in the Treatment of Indian Participants With Active Spondyloarthropathy of Ankylosing Spondylitis or Psoriatic Arthritis
Clinical trial NCT03733925 · COMPLETED
Trial details
- NCT number
- NCT03733925
- Sponsor
- Johnson & Johnson Private Limited
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-07
- Primary completion
- 2021-11-15
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.